Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on May 02, 2024 >>   ABB 6679.35 [ 2.09 ]ACC 2527.9 [ -0.13 ]AMBUJA CEM 625.4 [ 0.92 ]ASIAN PAINTS 2973.8 [ 3.36 ]AXIS BANK 1149.75 [ -1.41 ]BAJAJ AUTO 9103.8 [ 2.20 ]BANKOFBARODA 279.3 [ -0.82 ]BHARTI AIRTE 1306.15 [ -1.26 ]BHEL 292.65 [ 3.91 ]BPCL 634.8 [ 4.45 ]BRITANIAINDS 4760.25 [ -0.22 ]CIPLA 1419.55 [ 1.31 ]COAL INDIA 453.25 [ -0.23 ]COLGATEPALMO 2811.4 [ -0.47 ]DABUR INDIA 524.3 [ 3.30 ]DLF 895.8 [ 0.43 ]DRREDDYSLAB 6288.3 [ 1.34 ]GAIL 205 [ -1.91 ]GRASIM INDS 2434.3 [ 0.97 ]HCLTECHNOLOG 1360.4 [ -0.52 ]HDFC 2729.95 [ -0.62 ]HDFC BANK 1533 [ 1.05 ]HEROMOTOCORP 4562.45 [ 0.44 ]HIND.UNILEV 2225.45 [ -0.24 ]HINDALCO 641.4 [ -0.39 ]ICICI BANK 1139.9 [ -1.05 ]IDFC 121.35 [ -0.29 ]INDIANHOTELS 575.95 [ -0.14 ]INDUSINDBANK 1505.7 [ -0.65 ]INFOSYS 1414.85 [ -0.44 ]ITC LTD 439.1 [ 0.80 ]JINDALSTLPOW 941.85 [ 1.15 ]KOTAK BANK 1575.8 [ -2.95 ]L&T 3597.6 [ 0.10 ]LUPIN 1647.75 [ 0.14 ]MAH&MAH 2184.45 [ 1.31 ]MARUTI SUZUK 12793.75 [ -0.10 ]MTNL 38.04 [ -2.34 ]NESTLE 2511.3 [ 0.21 ]NIIT 105.25 [ -0.47 ]NMDC 258.45 [ 1.63 ]NTPC 369.35 [ 1.72 ]ONGC 282.65 [ -0.07 ]PNB 138 [ -2.20 ]POWER GRID 313.45 [ 3.91 ]RIL 2932.1 [ 0.03 ]SBI 830.05 [ 0.53 ]SESA GOA 410.7 [ 3.22 ]SHIPPINGCORP 227.55 [ -0.07 ]SUNPHRMINDS 1518.4 [ 1.07 ]TATA CHEM 1100.7 [ 2.65 ]TATA GLOBAL 1091.15 [ -1.51 ]TATA MOTORS 1027.95 [ 1.99 ]TATA STEEL 167.35 [ 1.45 ]TATAPOWERCOM 457.7 [ 1.91 ]TCS 3863.75 [ 1.08 ]TECH MAHINDR 1266.9 [ 0.39 ]ULTRATECHCEM 9981.25 [ 0.15 ]UNITED SPIRI 1194.3 [ 1.56 ]WIPRO 457.25 [ -1.09 ]ZEETELEFILMS 143.9 [ -2.11 ] BSE NSE
You can view the entire text of Notes to accounts of the company for the latest year
No Data Available
Year End :2012-03 
1. COPORATE INFORMATION

Anu's Laboratories Limited is one of the leading manufacturers of 2,4- Dichloro-5 Fluro Acetophenone, CSI Hydroxy Lactum, Chlorohexanone 2-one, Q-acid, Sodium Methoxide solution and powder. Anu's Laboratories Limited has manufacturing facilities at Shad Nagar, Isnapur, Visakapatnam and Pydibhimavaram in Andhra Pradesh.

The financial statements of the Company are prepared on accrual basis.

2.1 Long-term loan from bank: The loan from ING Vysya Bank Limited is secured by way of exclusive first charge on fixed assets of the Company situated at Jawaharlal Nehru Pharma City, Parwada, Vizag. This facility is further secured by way of pari pasu first charge on all other fixed assets of the Company, both present & future, along with other term lenders. The loan is repayable in 12 quarterly installments and the last being October 2014 and carries rate of interest of 16%.

2.2 Long-term loan from others: The loan from IFCI Venture Capital Funds Limited and is secured by way of exclusive first charge on fixed assets of the Company situated at Pydibhimavaram, Srikakulam District, Andhra Pradesh. This facility is secured by way of pledge of shares of promoters of the Company and also guaranteed by the Managing Director of the Company. The loan is repayable in 9 quarterly installments and the last installment being in January 2014 and carries rate of interest of 16%.

2.3 Finance lease obligations are secured against leased assets (Refer Note 13.1).

2.4 Unsecured loan: The long term unsecured loan of Rs.170.00 million from Shri Ram City Union Finance Limited secured against personal property of the promoters and repayable in one year and carrying rate of interest @ 24% p.a.

2.5 The working capital facilities are sanctioned by IDBI, State Bank of India, ING Vysya Bank and Karur Vysya Bank. These facilities are secured by first charge on all the current assets, both present & future. There are further secured by way of second charge on the immovable properties of the Company. These are further secured by way of paripassu first charge on the properties belongs to the promoters & relatives of the promoters and also guaranteed by the Promoter Directors and Directors of the Company. These loans are payable on demand and carry average rate of interest 15% p.a.

3. General description of lease terms

a. Lease rentals are charges on the basis of agreed terms

b. Assets are taken on lease for a period of five years

4. CONTINGENT LIABILITIES

Particulars                                    2011-12     2010-11

a.  Bank guarantees & letter of
credit given by banks                            11.67      413.98
b. Details of statutory authorities disputed by the Company in appeals with higher authorities in respect of:

Disputed sales tax demands

A.Y. 2001-02                                      1.00        1.00

A.Y. 2003-04                                      0.68        0.68

A.Y. 2004-05                                      1.82        1.82

A.Y. 2005-06                                      2.21        2.21
c. Other legal claims

M/s. Sun Moon Chemicals Private Limited 
filled a suit against the Company for a
demand of Rs.4.68 million.                        4.68        4.68

Total                                            22.06      424.37
5. SEGMENT REPORTING

a. Company's operations are predominantly related to the manufacture of bulk drugs intermediates, as such there is only one primary reportable segment. Secondary reportable segments are identified taking into account the geographical markets available to the products, the differing risks, returns and internal reporting system.

b. As a part of secondary reporting, revenues are attributed to geographical areas based on the location of customers as detailed below:

6. REGROUPED

Previous year's figures have been regrouped/reclassified wherever necessary, to confirm to the current year classification.